DP
IVA icon

Diadema Partners’s Inventiva IVA Stock Holding History

Diadema Partners’s Portfolio IVA Stock Details IVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.73M Buy
740,786
+388,387
+110% +$1.87M 0.34% 66
2026
Q1 		$1.94M Buy
352,399
+18,148
+5% +$111K 0.33% 63
2025
Q4 		$1.55M Buy
+334,251
New +$1.55M 0.27% 76

Other funds holding IVA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM

Diadema Partners's IVA Position: Q2 2026 in Review

Diadema Partners increased its Inventiva (IVA) stake by 110% in Q2 2026, buying an estimated $1.87M and bringing the position to 740,786 shares worth $2.73M. The position accounts for 0.34% of the portfolio, ranked #66.

Diadema Partners first reported a position in IVA in Q4 2025 and has held it in 3 quarters since. 88 funds tracked by Wall St. Rank hold IVA as of Q2 2026.

  • Diadema Partners held 740,786 shares of Inventiva worth $2.73M as of Q2 2026.
  • Diadema Partners bought 388,387 Inventiva shares in Q2 2026, an estimated $1.87M.
  • Inventiva made up 0.34% of Diadema Partners's portfolio in Q2 2026, its #66 holding.
  • Diadema Partners first reported a position in Inventiva in Q4 2025 and has held it in 3 quarters since.
  • 88 funds tracked by Wall St. Rank held Inventiva as of Q2 2026.

Based on Diadema Partners's 13F filing for Q2 2026, filed 14 Aug 2026.